Robotic Cardiac Surgery: Is It Resevred To Only Low Risk Patient Only?
Feras Khaliel, Zainab ALAYED, Faisal Alshamdin, Faisal Fallatah, Shahid Khan, Mohammed Alamri, Maie Alshahed, Aly Alsanei, Zohair Alhalees, Adel Aly.
King Faisal Specialist Hospital & Research Center, RIyadh, Saudi Arabia.
INTRODUCTION:Robotic cardiac surgery is a sophisticated procedure which has been limited to certain extra-cardiac and some intra-cardiac low risk surgery. Our study to determine medium- and high-risk outcome patients. METHODS:Between to Feb.2019, June2021, 158 patients underwent robotic cardiac surgery (intra and extra-cardiac). Mean age 48±14yrs, 34% were male. Mean BMI 29±7.3kg/m2. History of DM 49%, HTN 58%, Severe PHTN 64%, Chronic A. Fib. 55%, CKD & Dialysis 11%, 4%, respectively. Previous Stroke 12%, CHF 17% and STS score of 1-4 in 83%, 5-8 in 9.5%, >8% in 6.5%. Previous cardiac surgery in 12.6%. RESULTS:Hospital and 2-year Survival were 98% & 96%, respectively. Freedom of blood transfusions in 30%, and <3 units in 42%. Median LOS 6 days and LOS<7days in 56%. Ultrafast track and Fast track extubation were in 23.4%, 57%, respectively. Postop Stroke 2%, SSI 8.9%, new incidence of A. Fib 19%, AKI and dialysis 17%, 3.8%, respectively. Weaning CPB on ECMO 3.2%. CONCLUSION:Despite the high-risk patient cohort, obesity and previous history cardiac surgery robotic cardiac surgery improves patient’s postop journey, LOS, morbidity and mortality, once learning is achieved 
Back to 2022 Display ePosters